That's interesting. I didn't realize he had been an advisor.
The focus on delivery is probably because that's the upgrade, the valve itself is still the Evolut Pro, which Medtronic does promote as having excellent hemodynamics in their marketing materials, which every company does whether the hemodynamics are relatively excellent or not, so I don't think them not mentioning hemodynamics in the CE Mark press release means anything.
AVR Price at posting:
$20.25 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)